Talampanel to Treat Parkinson's Disease

NCT00108667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: IV Levodopa
DRUG: Talampanel

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)